









Markets
/
Stocks
/
nasdaq-tnon
/

Tenon Medical Inc

TNON

1.260USD

+0.020+1.61%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

9.57MMarket Cap

LossP/E TTM



Tenon Medical Inc

1.260

+0.020+1.61%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a strong stock market performance and outperforming fundamentals, the technicals don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

134 / 207

Overall Ranking

334 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 2 analysts

Buy

Current Rating

2.875

Target Price

+131.85%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The Company has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 374.24% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 3.28M.

Overvalued

The company’s latest PE is 0.23, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 215.62K shares, decreasing 13.10% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 7.10K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of -0.10.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 6.12, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 564.00K, representing a year-over-year decrease of 37.40%, while its net profit experienced a year-over-year decrease of 27.63%.

Score

Industry at a Glance

Previous score

6.12

Change



Financials

8.95

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.31

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.77

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

4.46

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.09

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 4.10, which is higher than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is 0.22, which is -157.19% below the recent high of -0.13 and 282.99% above the recent low of -0.41.

Score

Industry at a Glance

Previous score

4.10

Change

1.15

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 134/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Tenon Medical Inc is 3.00, with a high of 12.00 and a low of 2.75.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts

Buy

Current Rating

2.875

Target Price

+131.85%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Tenon Medical Inc

TNON

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 1.37, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 1.50 and the support level at 1.04, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

1.37

Change

0.01

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.003

Neutral

RSI(14)

51.838

Neutral

STOCH(KDJ)(9,3,3)

83.338

Buy

ATR(14)

0.076

Low Volatility

CCI(14)

140.106

Buy

Williams %R

16.694

Overbought

TRIX(12,20)

-0.501

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

1.210

Buy

MA10

1.193

Buy

MA20

1.234

Buy

MA50

1.241

Buy

MA100

1.146

Buy

MA200

1.376

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 2.81%, representing a quarter-over-quarter decrease of 82.15%. The largest institutional shareholder is The Vanguard, holding a total of 7.10K shares, representing 0.08% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

SBI Securities Co., Ltd.

2.01K

+201300.00%

Spectrum Asset Management, Inc. (NB/CA)

25.65K

Geode Capital Management, L.L.C.

20.05K

+12.36%

UBS Financial Services, Inc.

13.41K

+485.46%

Ginn (Richard)

10.99K

The Vanguard Group, Inc.

Star Investors

2.98K

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.02, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 1.27. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.